BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35398108)

  • 1. Courses of treatment and risk factors for treatment-resistant depression in Finnish primary and special healthcare: A nationwide cohort study.
    Lähteenvuo M; Taipale H; Tanskanen A; Rannanpää S; Tiihonen J
    J Affect Disord; 2022 Jul; 308():236-242. PubMed ID: 35398108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study.
    Lundberg J; Cars T; Lööv SÅ; Söderling J; Sundström J; Tiihonen J; Leval A; Gannedahl A; Björkholm C; Själin M; Hellner C
    JAMA Psychiatry; 2023 Feb; 80(2):167-175. PubMed ID: 36515938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Finding factors that predict treatment-resistant depression: Results of a cohort study.
    Cepeda MS; Reps J; Ryan P
    Depress Anxiety; 2018 Jul; 35(7):668-673. PubMed ID: 29786922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment resistant depression in women with peripartum depression.
    Cepeda MS; Kern DM; Nicholson S
    BMC Pregnancy Childbirth; 2019 Sep; 19(1):323. PubMed ID: 31477032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective Service Use and Health Care Costs of Medicaid Beneficiaries with Treatment-Resistant Depression.
    Olfson M; Amos TB; Benson C; McRae J; Marcus SC
    J Manag Care Spec Pharm; 2018 Mar; 24(3):226-236. PubMed ID: 29485948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Atypical Antipsychotic Augmentation Reduce Subsequent Treatment Failure More Effectively Among Depressed Patients with a Higher Degree of Treatment Resistance? A Meta-Analysis of Randomized Controlled Trials.
    Wang HR; Woo YS; Ahn HS; Ahn IM; Kim HJ; Bahk WM
    Int J Neuropsychopharmacol; 2015 Mar; 18(8):. PubMed ID: 25770098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment patterns in patients with treatment-resistant depression in Danish patients with major depressive disorder.
    Gronemann FH; Petersen J; Alulis S; Jensen KJ; Riise J; Ankarfeldt MZ; Solem EJ; Bødker N; Osler M
    J Affect Disord; 2021 May; 287():204-213. PubMed ID: 33799039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance use disorders and risk for treatment resistant depression: a population-based, nested case-control study.
    Brenner P; Brandt L; Li G; DiBernardo A; Bodén R; Reutfors J
    Addiction; 2020 Apr; 115(4):768-777. PubMed ID: 31656053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare utilization, costs, and productivity losses in treatment-resistant depression in Finland - a matched cohort study.
    Taipale H; Lähteenvuo M; Tanskanen A; Huoponen S; Rannanpää S; Tiihonen J
    BMC Psychiatry; 2022 Jul; 22(1):484. PubMed ID: 35854248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment patterns and healthcare utilization of patients with treatment-resistant depression estimated using health insurance database: A population-based study from Taiwan.
    Huang WL; Chiang CL; Wu CS; Liao SC; Chien TH; Tseng CH; Tang CH
    J Affect Disord; 2022 Dec; 319():40-47. PubMed ID: 36096374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An episode level evaluation of the treatment journey of patients with major depressive disorder and treatment-resistant depression.
    Wu B; Cai Q; Sheehan JJ; Benson C; Connolly N; Alphs L
    PLoS One; 2019; 14(8):e0220763. PubMed ID: 31393922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?
    Dodd S; Bauer M; Carvalho AF; Eyre H; Fava M; Kasper S; Kennedy SH; Khoo JP; Lopez Jaramillo C; Malhi GS; McIntyre RS; Mitchell PB; Castro AMP; Ratheesh A; Severus E; Suppes T; Trivedi MH; Thase ME; Yatham LN; Young AH; Berk M
    World J Biol Psychiatry; 2021 Sep; 22(7):483-494. PubMed ID: 33289425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Incident Treatment-Resistant Depression: A Model Designed for Health Systems of Care.
    Liberman JN; Davis T; Pesa J; Chow W; Verbanac J; Heverly-Fitt S; Ruetsch C
    J Manag Care Spec Pharm; 2020 Aug; 26(8):987-995. PubMed ID: 32715964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current treatments used in clinical practice for major depressive disorder and treatment resistant depression in England: A retrospective database study.
    Denee T; Kerr C; Ming T; Wood R; Tritton T; Middleton-Dalby C; Massey O; Desai M
    J Psychiatr Res; 2021 Jul; 139():172-178. PubMed ID: 34077893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment-resistant depression as risk factor for substance use disorders-a nation-wide register-based cohort study.
    Brenner P; Brandt L; Li G; DiBernardo A; Bodén R; Reutfors J
    Addiction; 2019 Jul; 114(7):1274-1282. PubMed ID: 30938020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic impact of treatment-resistant depression: A retrospective observational study.
    Pérez-Sola V; Roca M; Alonso J; Gabilondo A; Hernando T; Sicras-Mainar A; Sicras-Navarro A; Herrera B; Vieta E
    J Affect Disord; 2021 Dec; 295():578-586. PubMed ID: 34509073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polygenic risk scores of lithium response and treatment resistance in major depressive disorder.
    Xiong Y; Karlsson R; Song J; Kowalec K; Rück C; Sigström R; Jonsson L; Clements CC; Andersson E; Boberg J; Lewis CM; Sullivan PF; Landén M; Lu Y
    Transl Psychiatry; 2023 Sep; 13(1):301. PubMed ID: 37770441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis.
    Pilon D; Joshi K; Sheehan JJ; Zichlin ML; Zuckerman P; Lefebvre P; Greenberg PE
    PLoS One; 2019; 14(10):e0223255. PubMed ID: 31600244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of treatment resistant depression episodes in a cohort of patients from a US commercial claims database.
    Kubitz N; Mehra M; Potluri RC; Garg N; Cossrow N
    PLoS One; 2013; 8(10):e76882. PubMed ID: 24204694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of early and lifetime clinical features and comorbidities for the risk of developing treatment-resistant depression in a 13-year nationwide cohort study.
    Huang SS; Chen HH; Wang J; Chen WJ; Chen HC; Kuo PH
    BMC Psychiatry; 2020 Nov; 20(1):541. PubMed ID: 33203427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.